Influence of parenteral iron therapy and oral vitamin E supplementation on neutrophil respiratory burst in chronic hemodialysis patients

Renal Failure

Volumn 27, Issue 2, 2005, Pages 135-141

  Hodkova, Magdalena ^a   Dusilova Sulkova, Sylvie ^b   Skalicka, Anna ^c   Kalousova, Marta ^a   Zima, Tomas ^a   Bartunkova, Jirina ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Advanced oxidation protein products; Atherosclerosis; Chemiluminescence; Hemodialysis; Intravenous iron; Neutrophil respiratory burst; Oxidative stress; Vitamin E

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ALPHA TOCOPHEROL; FERRIC GLUCONATE; IRON; OXYGEN RADICAL; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATTENUATION; BIOCOMPATIBILITY; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HEMODIALYSIS; HUMAN; IRON THERAPY; MALE; NEUTROPHIL; OXIDATION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY BURST; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; AGED; BIOCOMPATIBLE MATERIALS; CASE-CONTROL STUDIES; CHEMILUMINESCENT MEASUREMENTS; FEMALE; FERRIC COMPOUNDS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; RESPIRATORY BURST; VITAMIN E;

EID: 15344350695     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200048245     Document Type: Article

References (22)

1. Amore, A.; Coppo, R. Immunological basis of inflammation in dialysis. Nephrol. Dial. Transplant. 2002, 17 (Suppl 8), 16-24.
2. Stenvinkel, P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif. 2001, 19, 53-61.
3. Klein, J.B.; McLeish, K.R.; Ward, R.A. Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst. Am. J. Kidney Dis. 1999, 33, 483-491.
4. Deicher, R.; Hörl, W.H. Intravenous iron: the iatrogenic kick to lose control over oxygen? Kidney Blood Press. Res. 2002, 25, 284-288.
5. Fishbane, S. Intravenous iron therapy: reweighing risk and reward. Sem. Dial. 1999, 12 (1), 5-8.
6. Lim, P.-S.; Wei, Y.-H.; York Leng, Y.; Kho, B. Enhanced oxidative stress in hemodialysis patients receiving intravenous iron therapy. Nephrol. Dial. Transplant. 1999, 14, 2680-2687.
7. 2-isoprostanes following intravenous iron infusion in patients on hemodialysis. Kidney Int. 2001, 60, 1525-1531.
8. Tovbin, D.; Mazor, D.; Vorobiov, M.; Chaimovitz, C.; Meyerstein, N. Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation. Am. J. Kidney Dis. 2002, 40, 1005-1012.
9. Patruta, S.I.; Edlinger, R.; Sunder-Plassman, G.; Hörl, W.H. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J. Am. Soc. Nephrol. 1998, 9 (4), 655-663.
10. Guo, D.; Jaber, B.L.; Lee, S.; Perianayagan, M.C.; King, A.J.; Pereira, B.J.; Balakrishnan, V.S. Impact of iron dextran on polymorphonuclear cell function among HD patients. Clin. Nephrol. 2002, 58 (2), 134-142.
11. van Asbeck, B.S.; Marx, J.J.M.; Struyvenberg, A.; van Kats, J.H.; Verhoef, J. Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes. J. Immunol. 1984, 132, 851-856.
12. Tsuruoka, S.; Kawaguchi, A.; Nishiki, K.; Hayasaka, T.; Fukushima, C.; Sugimoto, K.; Saito, T.; Fujimura, A. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am. J. Kidney Dis. 2002, 39 (1), 127-133.
13. Harper, L.; Nuttall, S.L.; Martin, U.; Savage, C.O. Adjuvant treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis with vitamins E and C reduces superoxide production by neutrophils. Rheumatology 2002, 41 (3), 274-278.
14. Omata, M.; Higuchi, C.; Demura, R.; Sanaka, T.; Nihei, H. Reduction of neutrophil activation by vitamin E modified dialyzer membranes. Nephron 2000, 85 (3), 221-231.
15. Roob, J.M.; Khoschsorur, G.; Tiran, A.; Horina, J.H.; Holzer, H.; Winklhofer-Roob, B.M. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J. Am. Soc. Nephrol. 2000, 11, 539-549.
16. Koenig, J.S.; Fischer, M.; Bulant, E.; Tiran, B.; Elmadfa, I.; Druml, W. Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien. Klin. Wochenschr. 1997, 109 (1), 13-19.
17. Metcalf, J.A.; Gallin, J.I.; Nauseef, W.M.; Root, R.K. Laboratory Manual of Neutrophil Function; Raven Press: New York, 1986.
18. Witko-Sarsat, V.; Nguyen-Khoa, T.; Jungers, P.; Drucke, T.B.; Deschamps-Latscha, B. Advanced oxidation protein products as novel molecular basis of oxidative stress in uremia. Nephrol. Dial. Transplant. 1999, 14 (Suppl 1), 76-78.
19. Iijima, S.; Otsuka, F.; Hasegawa, Y.; Koyama, A. Hemodialysis neutropenia correlates with a decreased filterability and an increase in the number of cytoplasmic actin filaments in peripheral blood neutrophils, which is preceded by a decrease in the number of surface expression of L-selectin. Nephron 1999, 82 (3), 214-220.
20. Hoenich, N.A.; Woffindin, C.; Brennan, A.; Cox, P.J.; Matthews, J.N.; Goldfinch, M. A comparison of three brands of polysulfone membranes. J. Am. Soc. Nephrol. 1996, 7 (6), 871-876.
21. Kalousova, M.; Zima, T.; Tesar, V.; Skrha, J.; Stipek, S. Estimation of advanced glycation end products and advanced oxidation protein products. Klin. Biochem. Metab. 2002, 1, 11-16.
22. Chan, S.S.; Monteiro, H.P.; Schindler, F.; Stern, A.; Junqueira, V.B. Alpha-tocopherol modulates phosphorylation in human neutrophils by inhibition of protein kinase C activity and activation of tyrosine phosphatases. Free Radic. Res. 2001, 35 (6), 843-856.